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Leukocyte adhesion: Two selectins converge on sulphate
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Selectins mediate the attachment of leukocytes to
endothelial cells and to platelets under conditions of
blood flow. Sulphation of the ligands for two of the
selectins is required for optimal cell–cell interactions.
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The selectins are a family of cell–cell adhesion proteins
that participate in leukocyte–endothelial and leukocyte–
platelet interactions [1–4]. The family consists of three
members: P-selectin, expressed on activated endothelium
and platelets; E-selectin, expressed on activated endothe-
lium; and L-selectin, expressed on circulating leukocytes
(Fig. 1). During the process of leukocyte emigration into
inflammatory sites or lymphoid organs, the selectins are
thought to initiate and sustain the rolling of blood-borne
leukocytes on the endothelial surface. Subsequently,
integrins on the leukocyte become activated and engage
specific immunoglobulin-like counter-receptors on the
endothelium, leading to the arrest of the leukocyte and
extravasation into the tissue [5]. 
The selectins were named for the C-type lectin domains
at their amino termini (Fig. 1) and their function in the
recognition of specific cell-surface carbohydrates. The
nature of the carbohydrates, and of the cell-surface macro-
molecules that bear them has been an area of intense
scrutiny [1,6,7]. A major motivation is the development of
selectin antagonists to prevent the abnormal entry of
leukocytes into tissues during pathological inflammatory
reactions [1,7]. In 1990–1991, a seminal advance was the
discovery that the tetrasaccharide sialyl Lewis x (sLex;
Fig. 2) is recognized by all three selectins. P-selectin and
L-selectin also bind to a number of sulphated or phospho-
rylated compounds which bear no apparent relationship to
sLex [6].
The selectins have distinct binding specificities for the
relevant target cells, which has prompted the search for
specific glycoprotein ligands [2,7]. As summarized in
Figure 1
The domain organization of the three selectins
and their physiological ligands. PSGL-1 is the
dominant neutrophil ligand for P-selectin; it is
also present on other leukocytes. Some of the
O-linked oligosaccharides contain sialyl
Lewisx-related structures. The amino-terminal
region bears three potential sites for tyrosine
sulphation, at least one of which is used.
GlyCAM-1, an L-selectin ligand, is secreted
and may perform signaling functions in the
recruitment of lymphocytes to lymph nodes. It
contains sulphated, sialylated and fucosylated
oligosaccharides (see Fig. 2). The
carbohydrate structures of CD34 and a
subset of MAdCAM-1 are thought to be
similar to those on GlyCAM-1. The E-selectin
ligand, ESL-1 is predicted to bear up to five
N-linked oligosaccharides, at least some of
which are sialylated and fucosylated. Not
shown in the figure are several ligands which
have been described at the biochemical level
[1,2]: Sgp200 and heparan sulphate
proteoglycans for L-selectin; a 160 kD ligand
for P-selectin; and ~ 200 kD (CLA) and
250 kD ligands for E-selectin.
Figure 1, a number of ligands have now been identified.
The best characterized of these is PSGL-1, which medi-
ates P-selectin-dependent adhesive interactions under
both static and flow conditions [2]. In the case of L-
selectin, the situation is more complex, in that multiple
ligands have been identified [1,4,6], including GlyCAM-1,
CD34, Sgp200, MAdCAM-1 — all associated with high
endothelial venules (HEVs) in mouse lymphoid organs —
as well as heparan sulphate proteoglycans from cultured
bovine endothelial cells. The functions of this constella-
tion of molecules in L-selectin-dependent recruitment to
lymphoid organs and inflammatory sites are undoubtedly
complex and remain to be elucidated. For E-selectin,
several myeloid ligands have also been identified. One of
these is PSGL-1, although E-selectin appears to utilize
distinct regions on PSGL-1, in addition to those recog-
nized by P-selectin [2]. Notably, several of the selectin
ligands (GlyCAM-1, CD34, MAdCAM-1 and PSGL-1),
but not all (for example, ESL-1), contain mucin-like
domains. 
An extensive series of experiments identified sLex or
related structures within PSGL-1, ESL-1, and the HEV-
associated ligands for L-selectin [6]. The question of
how the selectins achieve high affinity (104–105-fold
greater than to sLex) and selectivity in vivo has aroused
tremendous interest. A possible contributing factor to
avidity could be the multivalent presentation of sLex-
like determinants on mucin domains of the ligands.
Affinity, as well as selectivity, could also derive from dis-
tinctive features of the carbohydrate chains or the
protein core. As reviewed below, growing evidence indi-
cates that sulphation is a critical feature for two classes of
selectin ligands.
Sulphation of the principle HEV-associated ligands for
L-selectin (GlyCAM-1, CD34 and Sgp200) is well estab-
lished [1]. GlyCAM-1, the only ligand subjected to a
detailed biochemical analysis, shows intense metabolic
incorporation of sulphate into its O-glycans. Studies using
chlorate — a selective inhibitor of 3'-phosphoadenosine 5'
phosphosulphate synthesis (PAPS) — establish that sul-
phation is essential for the binding of the HEV ligands to
L-selectin and to MECA 79, a function-blocking mono-
clonal antibody [8]. Analysis of GlyCAM-1 has shown that
its O-glycans are extensively sulphated, with approxi-
mately equal contributions from Gal-6-sulphate and
GlcNAc-6-sulphate (see Fig. 2 legend for abbreviations).
The O-glycans comprise a complex array of chains of
varying length and degrees of sulphation, and only the
simplest of these structures has been deduced (Fig. 2) [9].
Notably, sLex capping groups modified with sulphate
esters on the 6 position of Gal or the 6 position of GlcNAc
are predicted to be major components of the GlyCAM-1
oligosaccharides. 
On the basis of these structures, a number of simple sul-
phated derivatives have now been synthesized and tested
for L-selectin binding. Sulphation of sLex on the 6-posi-
tion of GlcNAc increases its L-selectin-binding potency
four-fold in an equilibrium competition assay [10]. Fur-
thermore, a lactose derivative substituted on the 6′ posi-
tion of Gal (Fig. 2) shows significant L-selectin-binding
activity and is only two-fold less potent than sLex [11].
Significantly, a disulphated version of lactose, containing
sulphates on the 6 positions of both Gal and Glc, is actu-
ally two-fold more potent than sLex. These findings
suggest that both types of sulphate modifications found
within GlyCAM-1 contribute to L-selectin binding. The
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Figure 2
Predicted structures of the simplest O-
glycans from GlyCAM-1, as deduced by
metabolic radiolabeling studies. The
oligosaccharides bear the sLex
tetrasaccharide (highlighted) and are
sulphated on the 6 position of Gal (R1) and/or
the 6 position of GlcNAc (R2). Abbreviations:
Sia, sialic acid; Gal, galactose; GlcNAc,
N-acetylglucosamine; Fuc, fucose; GalNAc,
N-acetylgalactosamine.
relative importance of each modification and the nature of
the complete recognition determinants are unknown at
present. In addition, the contribution of these sulphate
esters to the kinetic parameters of ligand interaction has
not, as yet, been determined.
In the case of P-selectin, early experiments with selenate
(a metabolic inhibitor of sulphation) suggested the poten-
tial importance of sulphation for neutrophil ligands [12].
The molecular cloning of PSGL-1 reawakened interest in
this question, with the finding that three consensus sites
for tyrosine sulphation lie within the amino-terminal 10
amino acids of the mature protein [13]. In contrast,
GlyCAM-1, CD34, and MAdCAM-1 do not have any such
sites. Analysis of PSGL-1 derived from a neutrophil-like
cell line (HL60) confirmed that PSGL-1 is sulphated and
that all of the sulphate is bound to tyrosine residues [14].
Either removal of sulphate from PSGL-1 by an arylsul-
phatase, or cleavage of the first 10 amino acids from the
ligand by a cobra venom metalloproteinase, results in a
parallel loss of binding to P-selectin [14,15]. Strikingly, the
amino-terminal region bearing the sulphated tyrosines is
not required for E-selectin binding. 
Recombinant functional PSGL-1 can be produced in COS
cells by cotransfection of a cDNA encoding the core
protein and a cDNA for a fucosyltransferase, which can
give rise to sLex determinants [13]. A chimeric PSGL-1
linked to the Fc region of an antibody retains binding
activity for P-selectin, even when it contains only the first
19 residues of PSGL-1 [16]. This minimal fragment con-
tains the three potential tyrosine sulphation sites as well as
a single site that is used for O-glycosylation. The binding of
the truncated molecule depends on its fucosylation and
sialylation, as does the binding of the parent PSGL-1 mole-
cule. Mutation of either the tyrosines or the glycosylation
site dramatically reduces binding to P-selectin. In striking
contrast, tyrosine sulphation is not necessary for binding of
this minimal chimera or larger fragments to E-selectin,
although the same carbohydrate requirements apply. A
complementary study showed that appending the amino-
terminal region (20 residues) of PSGL-1 to the mucin-like
stalk of CD43 confers P-selectin-binding activity [17].
Again, optimal ligand activity requires the critical tyrosines
in the terminal segment and the appropriate carbohydrate
modifications. Taken together, this remarkable series of
studies leads to a two-site model for P-selectin binding to
PSGL-1, in which there is obligate dual recognition of an
anionic amino-terminal sulphated region and a
sialylated/fucosylated determinant (Fig. 3). By contrast,
recognition of PSGL-1 by E-selectin occurs independently
of the amino-terminal region. Thus, the selective use of
tyrosine sulphation provides one basis for the differential
recognition of PSGL-1 by the two endothelial selectins. 
Carbohydrate recognition undoubtedly resides within the
lectin domain of P-selectin, and some of the critical
residues underlying the binding of sLex have been
defined [4]. The site for recognition of tyrosine sulphates
may also reside within the lectin domain, but the neigh-
boring EGF-like domain must be considered as well (Fig.
1). The EGF domain is highly conserved across species, is
required for functional binding to ligands, and appears to
contribute to the specificity of P-selectin binding to
myeloid ligands [3]. These observations are consistent
with the direct participation of the EGF domain in recog-
nition of the ligand (the anionic amino-terminal peptide),
but a structural support role cannot be ruled out. The exis-
tence of a secondary binding site could explain why so
many anionic substances with no apparent structural rela-
tionship to sLex bind to P-selectin [6].
The nature of L-selectin binding to its sulphated physio-
logical ligands is more difficult to understand. In one
model, sulphation of the oligosaccharides on L-selectin
ligands may promote their interaction within the lectin
domain. Alternatively, a secondary site may be involved
in the recognition of these sulphated structures, while a
primary lectin-domain site interacts with sLex-like
oligosaccharides irrespective of sulphation. This second
model is similar to a previous one in which combinations
of oligosaccharides define the recognition structure [6].
The first model is supported by the observation that the
relative L-selectin-binding activity of sulphated oligosac-
charides is dependent on the positions of sulphation (see
above). In considering the second model, it is noteworthy
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Figure 3
The two-site model for binding of P- and L-selectins to their sulphated
physiological ligands. Site A on the selectin recognizes an
oligosaccharide determinant; site B recognizes an anionic determinant
on the cognate ligand. In GlyCAM-1, the oligosaccharides are
sulphated, sialylated and fucosylated; in PSGL-1 the oligosaccharides
are sialylated and fucosylated, but unsulphated. Site A in P-selectin
recognizes sLex-like oligosaccharides, while site B interacts with an
anionic amino-terminal region containing tyrosine sulphate. Site A lies
within the C-type lectin domain of P-selectin, whereas site B may be in
either the lectin domain or the EGF domain. The distinction between
sites A and B in L-selectin is less clear.
that the binding of L-selectin to the anionic phospholipid
cardiolipin has been localized to a positively charged
region within the lectin domain (residues 84–89,
Lys–Lys–Asn–Lys–Glu–Asp in human) [18]. This six-
residue sequence, which lies in close proximity to
residues involved in sLex binding [4], may comprise a
secondary binding site for anionic substances. In E-
selectin, this region has a net negative charge, which may
account for the observation that E-selectin does not
recognize the highly anionic substances that bind to
P-and L-selectins. 
The sites of attachment of sulphate esters to PSGL-1 and
GlyCAM-1 are different (protein versus carbohydrate), yet
both ligands have evolved a dependency on sulphation.
What are the special properties of sulphate that have led
to such a dramatic convergence of function? Sulphate
esters are fully ionized at physiological pH and augment
negative charge. Both L- and P-selectins have a large
number of basic amino acids in their lectin domains, sug-
gesting the possibility of favorable electrostatic inter-
actions with anionic sites on cognate ligands. Thus,
electrostatic attraction may explain the sulphation-depen-
dent binding of PSGL-1 and GlyCAM-1 to P-selectin and
L-selectin, respectively. 
Sulphate recognition may have an important impact on
the association rate of selectin–ligand binding. The
selectins must support leukocyte rolling under conditions
of rapid flow in the blood stream and high ‘on rates’ are
believed to be essential for this function [5]. Interestingly,
a relationship between electrostatic attraction and rapid
association rates has been previously documented. Many
DNA-binding proteins have regions of basic amino acids
that interact non-specifically with the anionic phospho-
diester backbone, resulting in an enhancement in associa-
tion rate by electrostatic attraction [19]. In fact,
attachment of basic peptides to a single-stranded oligo-
nucleotide can lead to dramatic increases in the rate of
association (48 000-fold) with a complementary nucleotide
strand [20]. An adhesion-related example is seen in the
interaction of the platelet GP Ib–IX complex with von
Willebrand factor (vWF) [21]. This shear-induced binding
event initiates the attachment of platelets to the blood
vessel wall at sites of injury, an event that must occur very
rapidly. Tyrosine sulphation within GP Iba, a component
of the complex, is essential for vWF binding. Thus, it is
striking that several molecules involved in rapidly occur-
ring adhesive events within the blood vascular compart-
ment share a dependency on sulphation. The possible
kinetic advantage conferred by sulphate may explain the
convergence of two selectins on this modification.
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